ARTICLE | Company News
MacroGenics, National Institutes of Health autoimmune, infectious news
July 26, 2010 7:00 AM UTC
MacroGenics received three grants from NIH totaling $9.8 million. MacroGenics said the first grant would be used to fund preclinical development of its Dual-Affinity Re-Targeting (DART) bispecific ant...